Topic: manufacturing issues
B. Braun Medical will invest $1 billion to build a new plant in Florida and expand two other facilities to help address U.S. IV fluid shortages.
GlaxoSmithKline is again having manufacturing issues with some of its inhalers, leading it to voluntarily recall products in markets outside the U.S.
The FDA is reorganizing its manufacturing inspections, saying the new system should speed drug approvals and reduce surprises for drugmakers.
Teva has halted production at the Rimsa plant in Mexico and idled some of the workers, laying the blame for the issues at the feet of the brothers with whom they are battling in court over the $2.3 billion buyout of the company.